Miguel Guia, Nilgun Alpay, António Gerardo, Yasmin Madney, Mohamed Abdelrahim, Haitham Saeed, Hadeer Harb, Gil Gonçalves, Bruno Cabrita, Jaber Alqahtani, Mohamad El-Khatib, Manuel Gómez-Ríos, Atefeh Fakharian, Laura Ciobanu, Habib Md Reazaul Karim, Edoardo Piervincenzi, Martin Scharffenberg, Paschalis Steiropoulos, William LeMaster, Igor Barjaktarevic, Jakob Wittenstein, Montserrat Diaz-Abad, Andreas Perren, Antonello Nicolini, Savino Spadaro, Giancarlo Garuti, Angelo Petroianni, Antonio Esquinas
{"title":"高流量鼻吸氧治疗急性低氧血症性呼吸衰竭:技术和初步方法的简要回顾。","authors":"Miguel Guia, Nilgun Alpay, António Gerardo, Yasmin Madney, Mohamed Abdelrahim, Haitham Saeed, Hadeer Harb, Gil Gonçalves, Bruno Cabrita, Jaber Alqahtani, Mohamad El-Khatib, Manuel Gómez-Ríos, Atefeh Fakharian, Laura Ciobanu, Habib Md Reazaul Karim, Edoardo Piervincenzi, Martin Scharffenberg, Paschalis Steiropoulos, William LeMaster, Igor Barjaktarevic, Jakob Wittenstein, Montserrat Diaz-Abad, Andreas Perren, Antonello Nicolini, Savino Spadaro, Giancarlo Garuti, Angelo Petroianni, Antonio Esquinas","doi":"10.5152/TurkThoracJ.2021.20213","DOIUrl":null,"url":null,"abstract":"<p><p>High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"494-500"},"PeriodicalIF":0.8000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975303/pdf/ttj-22-6-494.pdf","citationCount":"4","resultStr":"{\"title\":\"High-Flow Nasal Oxygen Therapy in Acute Hypoxemic Respiratory Failure: Concise Review on Technology and Initial Methodology.\",\"authors\":\"Miguel Guia, Nilgun Alpay, António Gerardo, Yasmin Madney, Mohamed Abdelrahim, Haitham Saeed, Hadeer Harb, Gil Gonçalves, Bruno Cabrita, Jaber Alqahtani, Mohamad El-Khatib, Manuel Gómez-Ríos, Atefeh Fakharian, Laura Ciobanu, Habib Md Reazaul Karim, Edoardo Piervincenzi, Martin Scharffenberg, Paschalis Steiropoulos, William LeMaster, Igor Barjaktarevic, Jakob Wittenstein, Montserrat Diaz-Abad, Andreas Perren, Antonello Nicolini, Savino Spadaro, Giancarlo Garuti, Angelo Petroianni, Antonio Esquinas\",\"doi\":\"10.5152/TurkThoracJ.2021.20213\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.</p>\",\"PeriodicalId\":37452,\"journal\":{\"name\":\"Turkish Thoracic Journal\",\"volume\":\"22 6\",\"pages\":\"494-500\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975303/pdf/ttj-22-6-494.pdf\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkish Thoracic Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5152/TurkThoracJ.2021.20213\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Thoracic Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/TurkThoracJ.2021.20213","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
High-Flow Nasal Oxygen Therapy in Acute Hypoxemic Respiratory Failure: Concise Review on Technology and Initial Methodology.
High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.
期刊介绍:
Turkish Thoracic Journal (Turk Thorac J) is the double-blind, peer-reviewed, open access, international publication organ of Turkish Thoracic Society. The journal is a quarterly publication, published on January, April, July, and October and its publication language is English. Turkish Thoracic Journal started its publication life following the merger of two journals which were published under the titles “Turkish Respiratory Journal” and “Toraks Journal” until 2007. Archives of both journals were passed on to the Turkish Thoracic Journal. The aim of the journal is to convey scientific developments and to create a dynamic discussion platform about pulmonary diseases. With this intent, the journal accepts articles from all related scientific areas that address adult and pediatric pulmonary diseases, as well as thoracic imaging, environmental and occupational disorders, intensive care, sleep disorders and thoracic surgery. Clinical and research articles, reviews, statements of agreement or disagreement on controversial issues, national and international consensus reports, abstracts and comments of important international articles, interesting case reports, writings related to clinical and practical applications, letters to the editor, and editorials are accepted.